Driving life sciences innovation through transactions
Locust Walk is a global investment bank that integrates corporate development strategy and execution with capital raising for innovative life science companies. We support management and board members through all aspects of a deal – from clearly defining and assessing all options to developing company positioning and navigating through the full transaction cycle from outreach to term sheet structuring to negotiating to close. Our suite of capabilities and data driven approach provides our clients with greater confidence in decision making, a rapidly deployable full team, and seamless integration working with us as one global team.
Japanese regional transaction with Viatris for specialty therapy for IgA nephropathy $20M upfront, $80M milestone plus royalties
NewCo Formation for Transcription Factor Network Pharmacology Platform
NewCo Formation for Thymic Regeneration and Immune Senescence Platforms
Corporate, R&D, BD, and financing strategy and commercial analytics with strategic transactions and capital markets execution
Global reach with on-the-ground local presence and company and investor relationships in all major life science markets
Each quarter we compile key statistics and trends on strategic transactions and financings.
You can download your report here.
A Track Record of Success
Locust Walk has supported our clients through more than 400 projects at the company, portfolio, and asset level generating nearly $10B of deal value spanning buy-side and sell-side transactions, and capital raises. Examples of recent client engagements click the link below. We would encourage you to click on each case study and/or press release to learn about each assignment in greater detail.